nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—CYP2A6—Tamoxifen—pancreatic cancer	0.095	0.143	CbGbCtD
Sevoflurane—CYP2E1—Dacarbazine—pancreatic cancer	0.0788	0.119	CbGbCtD
Sevoflurane—CYP2A6—Fluorouracil—pancreatic cancer	0.07	0.105	CbGbCtD
Sevoflurane—CYP2E1—Tamoxifen—pancreatic cancer	0.0627	0.0945	CbGbCtD
Sevoflurane—CYP2B6—Tamoxifen—pancreatic cancer	0.0619	0.0932	CbGbCtD
Sevoflurane—ALB—Erlotinib—pancreatic cancer	0.0516	0.0777	CbGbCtD
Sevoflurane—CYP2B6—Irinotecan—pancreatic cancer	0.0475	0.0716	CbGbCtD
Sevoflurane—ALB—Irinotecan—pancreatic cancer	0.0466	0.0701	CbGbCtD
Sevoflurane—ALB—Fluorouracil—pancreatic cancer	0.0447	0.0673	CbGbCtD
Sevoflurane—CYP2B6—Doxorubicin—pancreatic cancer	0.026	0.0391	CbGbCtD
Sevoflurane—CYP3A4—Tamoxifen—pancreatic cancer	0.019	0.0286	CbGbCtD
Sevoflurane—CYP3A4—Erlotinib—pancreatic cancer	0.0162	0.0243	CbGbCtD
Sevoflurane—CYP3A4—Irinotecan—pancreatic cancer	0.0146	0.022	CbGbCtD
Sevoflurane—CYP3A4—Docetaxel—pancreatic cancer	0.0107	0.0161	CbGbCtD
Sevoflurane—CYP3A4—Sunitinib—pancreatic cancer	0.0106	0.016	CbGbCtD
Sevoflurane—CYP3A4—Doxorubicin—pancreatic cancer	0.00797	0.012	CbGbCtD
Sevoflurane—Confusional state—Fluorouracil—pancreatic cancer	0.000471	0.00161	CcSEcCtD
Sevoflurane—Pharyngitis—Docetaxel—pancreatic cancer	0.000471	0.00161	CcSEcCtD
Sevoflurane—Urinary tract disorder—Docetaxel—pancreatic cancer	0.000468	0.0016	CcSEcCtD
Sevoflurane—Body temperature increased—Sunitinib—pancreatic cancer	0.000468	0.0016	CcSEcCtD
Sevoflurane—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000467	0.0016	CcSEcCtD
Sevoflurane—Oedema—Fluorouracil—pancreatic cancer	0.000467	0.0016	CcSEcCtD
Sevoflurane—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000465	0.0016	CcSEcCtD
Sevoflurane—Urethral disorder—Docetaxel—pancreatic cancer	0.000465	0.00159	CcSEcCtD
Sevoflurane—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000465	0.00159	CcSEcCtD
Sevoflurane—Renal failure acute—Doxorubicin—pancreatic cancer	0.000463	0.00159	CcSEcCtD
Sevoflurane—Skin disorder—Gemcitabine—pancreatic cancer	0.000461	0.00158	CcSEcCtD
Sevoflurane—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000458	0.00157	CcSEcCtD
Sevoflurane—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000457	0.00157	CcSEcCtD
Sevoflurane—Dizziness—Tamoxifen—pancreatic cancer	0.000457	0.00156	CcSEcCtD
Sevoflurane—Tachycardia—Fluorouracil—pancreatic cancer	0.000455	0.00156	CcSEcCtD
Sevoflurane—Hypotension—Irinotecan—pancreatic cancer	0.000455	0.00156	CcSEcCtD
Sevoflurane—Dizziness—Erlotinib—pancreatic cancer	0.000452	0.00155	CcSEcCtD
Sevoflurane—Hypotension—Gemcitabine—pancreatic cancer	0.000443	0.00152	CcSEcCtD
Sevoflurane—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.000442	0.00151	CcSEcCtD
Sevoflurane—Insomnia—Irinotecan—pancreatic cancer	0.000441	0.00151	CcSEcCtD
Sevoflurane—Cardiac disorder—Docetaxel—pancreatic cancer	0.00044	0.00151	CcSEcCtD
Sevoflurane—Cardiac arrest—Epirubicin—pancreatic cancer	0.00044	0.00151	CcSEcCtD
Sevoflurane—Vomiting—Tamoxifen—pancreatic cancer	0.000439	0.0015	CcSEcCtD
Sevoflurane—Hypotension—Fluorouracil—pancreatic cancer	0.000436	0.00149	CcSEcCtD
Sevoflurane—Hypersensitivity—Sunitinib—pancreatic cancer	0.000436	0.00149	CcSEcCtD
Sevoflurane—Rash—Tamoxifen—pancreatic cancer	0.000435	0.00149	CcSEcCtD
Sevoflurane—Dermatitis—Tamoxifen—pancreatic cancer	0.000435	0.00149	CcSEcCtD
Sevoflurane—Vomiting—Erlotinib—pancreatic cancer	0.000434	0.00149	CcSEcCtD
Sevoflurane—Dyspnoea—Irinotecan—pancreatic cancer	0.000434	0.00149	CcSEcCtD
Sevoflurane—Somnolence—Irinotecan—pancreatic cancer	0.000433	0.00148	CcSEcCtD
Sevoflurane—Headache—Tamoxifen—pancreatic cancer	0.000433	0.00148	CcSEcCtD
Sevoflurane—Rash—Erlotinib—pancreatic cancer	0.000431	0.00148	CcSEcCtD
Sevoflurane—Dermatitis—Erlotinib—pancreatic cancer	0.00043	0.00147	CcSEcCtD
Sevoflurane—Angiopathy—Docetaxel—pancreatic cancer	0.00043	0.00147	CcSEcCtD
Sevoflurane—Insomnia—Gemcitabine—pancreatic cancer	0.000429	0.00147	CcSEcCtD
Sevoflurane—Immune system disorder—Docetaxel—pancreatic cancer	0.000428	0.00147	CcSEcCtD
Sevoflurane—Headache—Erlotinib—pancreatic cancer	0.000428	0.00147	CcSEcCtD
Sevoflurane—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000427	0.00146	CcSEcCtD
Sevoflurane—Liver function test abnormal—Epirubicin—pancreatic cancer	0.000427	0.00146	CcSEcCtD
Sevoflurane—Chills—Docetaxel—pancreatic cancer	0.000425	0.00146	CcSEcCtD
Sevoflurane—Asthenia—Sunitinib—pancreatic cancer	0.000424	0.00145	CcSEcCtD
Sevoflurane—Arrhythmia—Docetaxel—pancreatic cancer	0.000423	0.00145	CcSEcCtD
Sevoflurane—Dyspnoea—Gemcitabine—pancreatic cancer	0.000423	0.00145	CcSEcCtD
Sevoflurane—Insomnia—Fluorouracil—pancreatic cancer	0.000422	0.00145	CcSEcCtD
Sevoflurane—Somnolence—Gemcitabine—pancreatic cancer	0.000422	0.00145	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000421	0.00144	CcSEcCtD
Sevoflurane—Pruritus—Sunitinib—pancreatic cancer	0.000418	0.00143	CcSEcCtD
Sevoflurane—Pain—Irinotecan—pancreatic cancer	0.000417	0.00143	CcSEcCtD
Sevoflurane—Dyspnoea—Fluorouracil—pancreatic cancer	0.000416	0.00143	CcSEcCtD
Sevoflurane—Mental disorder—Docetaxel—pancreatic cancer	0.000415	0.00142	CcSEcCtD
Sevoflurane—Somnolence—Fluorouracil—pancreatic cancer	0.000415	0.00142	CcSEcCtD
Sevoflurane—Malnutrition—Docetaxel—pancreatic cancer	0.000413	0.00141	CcSEcCtD
Sevoflurane—Nausea—Tamoxifen—pancreatic cancer	0.00041	0.00141	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.00041	0.0014	CcSEcCtD
Sevoflurane—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000407	0.00139	CcSEcCtD
Sevoflurane—Pain—Gemcitabine—pancreatic cancer	0.000406	0.00139	CcSEcCtD
Sevoflurane—Nausea—Erlotinib—pancreatic cancer	0.000406	0.00139	CcSEcCtD
Sevoflurane—Dysgeusia—Docetaxel—pancreatic cancer	0.000404	0.00138	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000403	0.00138	CcSEcCtD
Sevoflurane—Feeling abnormal—Irinotecan—pancreatic cancer	0.000401	0.00138	CcSEcCtD
Sevoflurane—Pain—Fluorouracil—pancreatic cancer	0.000399	0.00137	CcSEcCtD
Sevoflurane—Liver function test abnormal—Doxorubicin—pancreatic cancer	0.000395	0.00135	CcSEcCtD
Sevoflurane—Pancreatitis—Epirubicin—pancreatic cancer	0.000392	0.00134	CcSEcCtD
Sevoflurane—Dizziness—Sunitinib—pancreatic cancer	0.000391	0.00134	CcSEcCtD
Sevoflurane—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000391	0.00134	CcSEcCtD
Sevoflurane—Body temperature increased—Irinotecan—pancreatic cancer	0.000385	0.00132	CcSEcCtD
Sevoflurane—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000385	0.00132	CcSEcCtD
Sevoflurane—Vomiting—Sunitinib—pancreatic cancer	0.000376	0.00129	CcSEcCtD
Sevoflurane—Body temperature increased—Gemcitabine—pancreatic cancer	0.000375	0.00129	CcSEcCtD
Sevoflurane—Dysuria—Epirubicin—pancreatic cancer	0.000374	0.00128	CcSEcCtD
Sevoflurane—Rash—Sunitinib—pancreatic cancer	0.000373	0.00128	CcSEcCtD
Sevoflurane—Dermatitis—Sunitinib—pancreatic cancer	0.000373	0.00128	CcSEcCtD
Sevoflurane—Urticaria—Fluorouracil—pancreatic cancer	0.000371	0.00127	CcSEcCtD
Sevoflurane—Headache—Sunitinib—pancreatic cancer	0.000371	0.00127	CcSEcCtD
Sevoflurane—Syncope—Docetaxel—pancreatic cancer	0.00037	0.00127	CcSEcCtD
Sevoflurane—Body temperature increased—Fluorouracil—pancreatic cancer	0.000369	0.00126	CcSEcCtD
Sevoflurane—Loss of consciousness—Docetaxel—pancreatic cancer	0.000363	0.00124	CcSEcCtD
Sevoflurane—Pancreatitis—Doxorubicin—pancreatic cancer	0.000362	0.00124	CcSEcCtD
Sevoflurane—Hyperglycaemia—Epirubicin—pancreatic cancer	0.00036	0.00123	CcSEcCtD
Sevoflurane—Cough—Docetaxel—pancreatic cancer	0.00036	0.00123	CcSEcCtD
Sevoflurane—Hypersensitivity—Irinotecan—pancreatic cancer	0.000359	0.00123	CcSEcCtD
Sevoflurane—Convulsion—Docetaxel—pancreatic cancer	0.000358	0.00123	CcSEcCtD
Sevoflurane—Hypertension—Docetaxel—pancreatic cancer	0.000356	0.00122	CcSEcCtD
Sevoflurane—Chest pain—Docetaxel—pancreatic cancer	0.000351	0.0012	CcSEcCtD
Sevoflurane—Nausea—Sunitinib—pancreatic cancer	0.000351	0.0012	CcSEcCtD
Sevoflurane—Renal failure—Epirubicin—pancreatic cancer	0.00035	0.0012	CcSEcCtD
Sevoflurane—Asthenia—Irinotecan—pancreatic cancer	0.00035	0.0012	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000349	0.0012	CcSEcCtD
Sevoflurane—Jaundice—Epirubicin—pancreatic cancer	0.000347	0.00119	CcSEcCtD
Sevoflurane—Conjunctivitis—Epirubicin—pancreatic cancer	0.000346	0.00119	CcSEcCtD
Sevoflurane—Dysuria—Doxorubicin—pancreatic cancer	0.000346	0.00118	CcSEcCtD
Sevoflurane—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000344	0.00118	CcSEcCtD
Sevoflurane—Dry mouth—Docetaxel—pancreatic cancer	0.000344	0.00118	CcSEcCtD
Sevoflurane—Asthenia—Gemcitabine—pancreatic cancer	0.000341	0.00117	CcSEcCtD
Sevoflurane—Confusional state—Docetaxel—pancreatic cancer	0.00034	0.00116	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000337	0.00115	CcSEcCtD
Sevoflurane—Oedema—Docetaxel—pancreatic cancer	0.000337	0.00115	CcSEcCtD
Sevoflurane—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000337	0.00115	CcSEcCtD
Sevoflurane—Pruritus—Gemcitabine—pancreatic cancer	0.000336	0.00115	CcSEcCtD
Sevoflurane—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000333	0.00114	CcSEcCtD
Sevoflurane—Shock—Docetaxel—pancreatic cancer	0.000331	0.00114	CcSEcCtD
Sevoflurane—Nervous system disorder—Docetaxel—pancreatic cancer	0.00033	0.00113	CcSEcCtD
Sevoflurane—Pruritus—Fluorouracil—pancreatic cancer	0.00033	0.00113	CcSEcCtD
Sevoflurane—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00033	0.00113	CcSEcCtD
Sevoflurane—Tachycardia—Docetaxel—pancreatic cancer	0.000329	0.00113	CcSEcCtD
Sevoflurane—Skin disorder—Docetaxel—pancreatic cancer	0.000327	0.00112	CcSEcCtD
Sevoflurane—Bradycardia—Epirubicin—pancreatic cancer	0.000326	0.00112	CcSEcCtD
Sevoflurane—Renal failure—Doxorubicin—pancreatic cancer	0.000324	0.00111	CcSEcCtD
Sevoflurane—Dizziness—Irinotecan—pancreatic cancer	0.000322	0.0011	CcSEcCtD
Sevoflurane—Haemoglobin—Epirubicin—pancreatic cancer	0.000321	0.0011	CcSEcCtD
Sevoflurane—Jaundice—Doxorubicin—pancreatic cancer	0.000321	0.0011	CcSEcCtD
Sevoflurane—Conjunctivitis—Doxorubicin—pancreatic cancer	0.00032	0.0011	CcSEcCtD
Sevoflurane—Haemorrhage—Epirubicin—pancreatic cancer	0.00032	0.0011	CcSEcCtD
Sevoflurane—Hepatitis—Epirubicin—pancreatic cancer	0.00032	0.0011	CcSEcCtD
Sevoflurane—Pharyngitis—Epirubicin—pancreatic cancer	0.000317	0.00109	CcSEcCtD
Sevoflurane—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000316	0.00108	CcSEcCtD
Sevoflurane—Hypotension—Docetaxel—pancreatic cancer	0.000315	0.00108	CcSEcCtD
Sevoflurane—Urethral disorder—Epirubicin—pancreatic cancer	0.000313	0.00107	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000312	0.00107	CcSEcCtD
Sevoflurane—Vomiting—Irinotecan—pancreatic cancer	0.00031	0.00106	CcSEcCtD
Sevoflurane—Dizziness—Fluorouracil—pancreatic cancer	0.000309	0.00106	CcSEcCtD
Sevoflurane—Rash—Irinotecan—pancreatic cancer	0.000307	0.00105	CcSEcCtD
Sevoflurane—Dermatitis—Irinotecan—pancreatic cancer	0.000307	0.00105	CcSEcCtD
Sevoflurane—Headache—Irinotecan—pancreatic cancer	0.000305	0.00105	CcSEcCtD
Sevoflurane—Insomnia—Docetaxel—pancreatic cancer	0.000305	0.00104	CcSEcCtD
Sevoflurane—Vomiting—Gemcitabine—pancreatic cancer	0.000302	0.00103	CcSEcCtD
Sevoflurane—Bradycardia—Doxorubicin—pancreatic cancer	0.000301	0.00103	CcSEcCtD
Sevoflurane—Dyspnoea—Docetaxel—pancreatic cancer	0.0003	0.00103	CcSEcCtD
Sevoflurane—Somnolence—Docetaxel—pancreatic cancer	0.000299	0.00103	CcSEcCtD
Sevoflurane—Rash—Gemcitabine—pancreatic cancer	0.000299	0.00103	CcSEcCtD
Sevoflurane—Dermatitis—Gemcitabine—pancreatic cancer	0.000299	0.00102	CcSEcCtD
Sevoflurane—Haemoglobin—Doxorubicin—pancreatic cancer	0.000297	0.00102	CcSEcCtD
Sevoflurane—Headache—Gemcitabine—pancreatic cancer	0.000297	0.00102	CcSEcCtD
Sevoflurane—Cardiac disorder—Epirubicin—pancreatic cancer	0.000297	0.00102	CcSEcCtD
Sevoflurane—Vomiting—Fluorouracil—pancreatic cancer	0.000297	0.00102	CcSEcCtD
Sevoflurane—Haemorrhage—Doxorubicin—pancreatic cancer	0.000296	0.00101	CcSEcCtD
Sevoflurane—Hepatitis—Doxorubicin—pancreatic cancer	0.000296	0.00101	CcSEcCtD
Sevoflurane—Rash—Fluorouracil—pancreatic cancer	0.000294	0.00101	CcSEcCtD
Sevoflurane—Dermatitis—Fluorouracil—pancreatic cancer	0.000294	0.00101	CcSEcCtD
Sevoflurane—Pharyngitis—Doxorubicin—pancreatic cancer	0.000294	0.00101	CcSEcCtD
Sevoflurane—Headache—Fluorouracil—pancreatic cancer	0.000292	0.001	CcSEcCtD
Sevoflurane—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000292	0.001	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000291	0.000996	CcSEcCtD
Sevoflurane—Angiopathy—Epirubicin—pancreatic cancer	0.00029	0.000994	CcSEcCtD
Sevoflurane—Urethral disorder—Doxorubicin—pancreatic cancer	0.00029	0.000994	CcSEcCtD
Sevoflurane—Nausea—Irinotecan—pancreatic cancer	0.000289	0.000992	CcSEcCtD
Sevoflurane—Immune system disorder—Epirubicin—pancreatic cancer	0.000289	0.00099	CcSEcCtD
Sevoflurane—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000288	0.000988	CcSEcCtD
Sevoflurane—Pain—Docetaxel—pancreatic cancer	0.000288	0.000987	CcSEcCtD
Sevoflurane—Chills—Epirubicin—pancreatic cancer	0.000287	0.000983	CcSEcCtD
Sevoflurane—Arrhythmia—Epirubicin—pancreatic cancer	0.000286	0.000979	CcSEcCtD
Sevoflurane—Nausea—Gemcitabine—pancreatic cancer	0.000282	0.000966	CcSEcCtD
Sevoflurane—Mental disorder—Epirubicin—pancreatic cancer	0.00028	0.00096	CcSEcCtD
Sevoflurane—Malnutrition—Epirubicin—pancreatic cancer	0.000278	0.000954	CcSEcCtD
Sevoflurane—Feeling abnormal—Docetaxel—pancreatic cancer	0.000278	0.000951	CcSEcCtD
Sevoflurane—Nausea—Fluorouracil—pancreatic cancer	0.000277	0.00095	CcSEcCtD
Sevoflurane—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000275	0.000941	CcSEcCtD
Sevoflurane—Tension—Epirubicin—pancreatic cancer	0.000273	0.000936	CcSEcCtD
Sevoflurane—Dysgeusia—Epirubicin—pancreatic cancer	0.000273	0.000934	CcSEcCtD
Sevoflurane—Nervousness—Epirubicin—pancreatic cancer	0.00027	0.000926	CcSEcCtD
Sevoflurane—Angiopathy—Doxorubicin—pancreatic cancer	0.000268	0.00092	CcSEcCtD
Sevoflurane—Immune system disorder—Doxorubicin—pancreatic cancer	0.000267	0.000916	CcSEcCtD
Sevoflurane—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000267	0.000914	CcSEcCtD
Sevoflurane—Body temperature increased—Docetaxel—pancreatic cancer	0.000266	0.000912	CcSEcCtD
Sevoflurane—Chills—Doxorubicin—pancreatic cancer	0.000265	0.00091	CcSEcCtD
Sevoflurane—Arrhythmia—Doxorubicin—pancreatic cancer	0.000264	0.000906	CcSEcCtD
Sevoflurane—Mental disorder—Doxorubicin—pancreatic cancer	0.000259	0.000888	CcSEcCtD
Sevoflurane—Malnutrition—Doxorubicin—pancreatic cancer	0.000258	0.000883	CcSEcCtD
Sevoflurane—Agitation—Epirubicin—pancreatic cancer	0.000256	0.000877	CcSEcCtD
Sevoflurane—Tension—Doxorubicin—pancreatic cancer	0.000253	0.000866	CcSEcCtD
Sevoflurane—Dysgeusia—Doxorubicin—pancreatic cancer	0.000252	0.000864	CcSEcCtD
Sevoflurane—Nervousness—Doxorubicin—pancreatic cancer	0.00025	0.000857	CcSEcCtD
Sevoflurane—Syncope—Epirubicin—pancreatic cancer	0.00025	0.000855	CcSEcCtD
Sevoflurane—Hypersensitivity—Docetaxel—pancreatic cancer	0.000248	0.00085	CcSEcCtD
Sevoflurane—Loss of consciousness—Epirubicin—pancreatic cancer	0.000245	0.000838	CcSEcCtD
Sevoflurane—Cough—Epirubicin—pancreatic cancer	0.000243	0.000832	CcSEcCtD
Sevoflurane—Asthenia—Docetaxel—pancreatic cancer	0.000242	0.000828	CcSEcCtD
Sevoflurane—Convulsion—Epirubicin—pancreatic cancer	0.000241	0.000826	CcSEcCtD
Sevoflurane—Hypertension—Epirubicin—pancreatic cancer	0.00024	0.000824	CcSEcCtD
Sevoflurane—Pruritus—Docetaxel—pancreatic cancer	0.000238	0.000817	CcSEcCtD
Sevoflurane—Chest pain—Epirubicin—pancreatic cancer	0.000237	0.000812	CcSEcCtD
Sevoflurane—Agitation—Doxorubicin—pancreatic cancer	0.000237	0.000811	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000235	0.000807	CcSEcCtD
Sevoflurane—Dry mouth—Epirubicin—pancreatic cancer	0.000232	0.000794	CcSEcCtD
Sevoflurane—Syncope—Doxorubicin—pancreatic cancer	0.000231	0.000792	CcSEcCtD
Sevoflurane—Confusional state—Epirubicin—pancreatic cancer	0.000229	0.000785	CcSEcCtD
Sevoflurane—Oedema—Epirubicin—pancreatic cancer	0.000227	0.000779	CcSEcCtD
Sevoflurane—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000227	0.000779	CcSEcCtD
Sevoflurane—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000226	0.000776	CcSEcCtD
Sevoflurane—Cough—Doxorubicin—pancreatic cancer	0.000225	0.00077	CcSEcCtD
Sevoflurane—Shock—Epirubicin—pancreatic cancer	0.000224	0.000766	CcSEcCtD
Sevoflurane—Convulsion—Doxorubicin—pancreatic cancer	0.000223	0.000765	CcSEcCtD
Sevoflurane—Nervous system disorder—Epirubicin—pancreatic cancer	0.000223	0.000763	CcSEcCtD
Sevoflurane—Dizziness—Docetaxel—pancreatic cancer	0.000223	0.000763	CcSEcCtD
Sevoflurane—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000222	0.000762	CcSEcCtD
Sevoflurane—Hypertension—Doxorubicin—pancreatic cancer	0.000222	0.000762	CcSEcCtD
Sevoflurane—Tachycardia—Epirubicin—pancreatic cancer	0.000222	0.00076	CcSEcCtD
Sevoflurane—Skin disorder—Epirubicin—pancreatic cancer	0.000221	0.000756	CcSEcCtD
Sevoflurane—Chest pain—Doxorubicin—pancreatic cancer	0.000219	0.000751	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000218	0.000746	CcSEcCtD
Sevoflurane—Dry mouth—Doxorubicin—pancreatic cancer	0.000214	0.000735	CcSEcCtD
Sevoflurane—Vomiting—Docetaxel—pancreatic cancer	0.000214	0.000734	CcSEcCtD
Sevoflurane—Rash—Docetaxel—pancreatic cancer	0.000212	0.000728	CcSEcCtD
Sevoflurane—Hypotension—Epirubicin—pancreatic cancer	0.000212	0.000727	CcSEcCtD
Sevoflurane—Dermatitis—Docetaxel—pancreatic cancer	0.000212	0.000727	CcSEcCtD
Sevoflurane—Confusional state—Doxorubicin—pancreatic cancer	0.000212	0.000726	CcSEcCtD
Sevoflurane—Headache—Docetaxel—pancreatic cancer	0.000211	0.000723	CcSEcCtD
Sevoflurane—Oedema—Doxorubicin—pancreatic cancer	0.00021	0.00072	CcSEcCtD
Sevoflurane—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00021	0.00072	CcSEcCtD
Sevoflurane—Shock—Doxorubicin—pancreatic cancer	0.000207	0.000709	CcSEcCtD
Sevoflurane—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000206	0.000706	CcSEcCtD
Sevoflurane—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000206	0.000705	CcSEcCtD
Sevoflurane—Insomnia—Epirubicin—pancreatic cancer	0.000205	0.000704	CcSEcCtD
Sevoflurane—Tachycardia—Doxorubicin—pancreatic cancer	0.000205	0.000703	CcSEcCtD
Sevoflurane—Skin disorder—Doxorubicin—pancreatic cancer	0.000204	0.0007	CcSEcCtD
Sevoflurane—Dyspnoea—Epirubicin—pancreatic cancer	0.000203	0.000694	CcSEcCtD
Sevoflurane—Somnolence—Epirubicin—pancreatic cancer	0.000202	0.000692	CcSEcCtD
Sevoflurane—Nausea—Docetaxel—pancreatic cancer	0.0002	0.000686	CcSEcCtD
Sevoflurane—Hypotension—Doxorubicin—pancreatic cancer	0.000196	0.000673	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000196	0.000672	CcSEcCtD
Sevoflurane—Pain—Epirubicin—pancreatic cancer	0.000194	0.000666	CcSEcCtD
Sevoflurane—Insomnia—Doxorubicin—pancreatic cancer	0.00019	0.000652	CcSEcCtD
Sevoflurane—Dyspnoea—Doxorubicin—pancreatic cancer	0.000187	0.000642	CcSEcCtD
Sevoflurane—Feeling abnormal—Epirubicin—pancreatic cancer	0.000187	0.000642	CcSEcCtD
Sevoflurane—Somnolence—Doxorubicin—pancreatic cancer	0.000187	0.00064	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000181	0.000622	CcSEcCtD
Sevoflurane—Urticaria—Epirubicin—pancreatic cancer	0.00018	0.000618	CcSEcCtD
Sevoflurane—Pain—Doxorubicin—pancreatic cancer	0.00018	0.000616	CcSEcCtD
Sevoflurane—Body temperature increased—Epirubicin—pancreatic cancer	0.00018	0.000615	CcSEcCtD
Sevoflurane—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000173	0.000594	CcSEcCtD
Sevoflurane—Hypersensitivity—Epirubicin—pancreatic cancer	0.000167	0.000574	CcSEcCtD
Sevoflurane—Urticaria—Doxorubicin—pancreatic cancer	0.000167	0.000572	CcSEcCtD
Sevoflurane—Body temperature increased—Doxorubicin—pancreatic cancer	0.000166	0.000569	CcSEcCtD
Sevoflurane—Asthenia—Epirubicin—pancreatic cancer	0.000163	0.000559	CcSEcCtD
Sevoflurane—Pruritus—Epirubicin—pancreatic cancer	0.000161	0.000551	CcSEcCtD
Sevoflurane—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000155	0.000531	CcSEcCtD
Sevoflurane—Asthenia—Doxorubicin—pancreatic cancer	0.000151	0.000517	CcSEcCtD
Sevoflurane—Dizziness—Epirubicin—pancreatic cancer	0.00015	0.000515	CcSEcCtD
Sevoflurane—Pruritus—Doxorubicin—pancreatic cancer	0.000149	0.00051	CcSEcCtD
Sevoflurane—Vomiting—Epirubicin—pancreatic cancer	0.000144	0.000495	CcSEcCtD
Sevoflurane—Rash—Epirubicin—pancreatic cancer	0.000143	0.000491	CcSEcCtD
Sevoflurane—Dermatitis—Epirubicin—pancreatic cancer	0.000143	0.00049	CcSEcCtD
Sevoflurane—Headache—Epirubicin—pancreatic cancer	0.000142	0.000488	CcSEcCtD
Sevoflurane—Dizziness—Doxorubicin—pancreatic cancer	0.000139	0.000476	CcSEcCtD
Sevoflurane—Nausea—Epirubicin—pancreatic cancer	0.000135	0.000462	CcSEcCtD
Sevoflurane—Vomiting—Doxorubicin—pancreatic cancer	0.000134	0.000458	CcSEcCtD
Sevoflurane—Rash—Doxorubicin—pancreatic cancer	0.000133	0.000454	CcSEcCtD
Sevoflurane—Dermatitis—Doxorubicin—pancreatic cancer	0.000132	0.000454	CcSEcCtD
Sevoflurane—Headache—Doxorubicin—pancreatic cancer	0.000132	0.000451	CcSEcCtD
Sevoflurane—Nausea—Doxorubicin—pancreatic cancer	0.000125	0.000428	CcSEcCtD
Sevoflurane—KCNK18—Neuronal System—HRAS—pancreatic cancer	6.68e-05	0.0015	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GLP1R—pancreatic cancer	6.66e-05	0.0015	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GLP1R—pancreatic cancer	6.66e-05	0.0015	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—DPYD—pancreatic cancer	6.55e-05	0.00148	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—DPYD—pancreatic cancer	6.55e-05	0.00148	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	6.4e-05	0.00144	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.28e-05	0.00142	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	6.26e-05	0.00141	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—SLC2A2—pancreatic cancer	6.22e-05	0.0014	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—SLC2A2—pancreatic cancer	6.22e-05	0.0014	CbGpPWpGaD
Sevoflurane—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	6.19e-05	0.00139	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.19e-05	0.00139	CbGpPWpGaD
Sevoflurane—GRIA1—BDNF signaling pathway—HRAS—pancreatic cancer	6.05e-05	0.00136	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	5.85e-05	0.00132	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	5.78e-05	0.0013	CbGpPWpGaD
Sevoflurane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	5.56e-05	0.00125	CbGpPWpGaD
Sevoflurane—KCNK10—Neuronal System—HRAS—pancreatic cancer	5.44e-05	0.00123	CbGpPWpGaD
Sevoflurane—GRIA1—BDNF signaling pathway—AKT1—pancreatic cancer	5.34e-05	0.0012	CbGpPWpGaD
Sevoflurane—ALB—Platelet degranulation—EGF—pancreatic cancer	5.32e-05	0.0012	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	5.29e-05	0.00119	CbGpPWpGaD
Sevoflurane—KCNA1—Neuronal System—HRAS—pancreatic cancer	5.28e-05	0.00119	CbGpPWpGaD
Sevoflurane—KCNK2—Neuronal System—HRAS—pancreatic cancer	5.2e-05	0.00117	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	5.13e-05	0.00116	CbGpPWpGaD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—EGF—pancreatic cancer	5.07e-05	0.00114	CbGpPWpGaD
Sevoflurane—KCNK9—Neuronal System—HRAS—pancreatic cancer	5.06e-05	0.00114	CbGpPWpGaD
Sevoflurane—KCNK3—Neuronal System—HRAS—pancreatic cancer	5.06e-05	0.00114	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	5.04e-05	0.00114	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.96e-05	0.00112	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.92e-05	0.00111	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.83e-05	0.00109	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—CASP3—pancreatic cancer	4.83e-05	0.00109	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—CD44—pancreatic cancer	4.82e-05	0.00109	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—CD44—pancreatic cancer	4.82e-05	0.00109	CbGpPWpGaD
Sevoflurane—ALB—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	4.76e-05	0.00107	CbGpPWpGaD
Sevoflurane—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	4.69e-05	0.00106	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—CTNNB1—pancreatic cancer	4.65e-05	0.00105	CbGpPWpGaD
Sevoflurane—GRIA1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	4.65e-05	0.00105	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GCG—pancreatic cancer	4.62e-05	0.00104	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GCG—pancreatic cancer	4.62e-05	0.00104	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—STK11—pancreatic cancer	4.34e-05	0.000978	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—STK11—pancreatic cancer	4.34e-05	0.000978	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.23e-05	0.000952	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—SRC—pancreatic cancer	4.21e-05	0.000948	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	4.06e-05	0.000915	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—STAT3—pancreatic cancer	4.06e-05	0.000914	CbGpPWpGaD
Sevoflurane—ALB—Vitamin B12 Metabolism—TNF—pancreatic cancer	3.96e-05	0.000892	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	3.89e-05	0.000876	CbGpPWpGaD
Sevoflurane—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	3.86e-05	0.000871	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IFNA5—pancreatic cancer	3.82e-05	0.000862	CbGpPWpGaD
Sevoflurane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	3.8e-05	0.000857	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—PTGS2—pancreatic cancer	3.79e-05	0.000854	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	3.75e-05	0.000844	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—TYMS—pancreatic cancer	3.73e-05	0.000842	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—TYMS—pancreatic cancer	3.73e-05	0.000842	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PPP2R5B—pancreatic cancer	3.61e-05	0.000814	CbGpPWpGaD
Sevoflurane—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	3.6e-05	0.000811	CbGpPWpGaD
Sevoflurane—GRIA1—Neuronal System—HRAS—pancreatic cancer	3.56e-05	0.000803	CbGpPWpGaD
Sevoflurane—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	3.55e-05	0.000801	CbGpPWpGaD
Sevoflurane—GABRQ—Transmission across Chemical Synapses—HRAS—pancreatic cancer	3.53e-05	0.000795	CbGpPWpGaD
Sevoflurane—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	3.32e-05	0.000747	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	3.3e-05	0.000743	CbGpPWpGaD
Sevoflurane—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	3.25e-05	0.000733	CbGpPWpGaD
Sevoflurane—ALB—Platelet degranulation—VEGFA—pancreatic cancer	3.22e-05	0.000726	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—TNF—pancreatic cancer	3.22e-05	0.000726	CbGpPWpGaD
Sevoflurane—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	3.16e-05	0.000712	CbGpPWpGaD
Sevoflurane—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	3.1e-05	0.000699	CbGpPWpGaD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—pancreatic cancer	3.07e-05	0.000692	CbGpPWpGaD
Sevoflurane—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	3.05e-05	0.000687	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—APOE—pancreatic cancer	3.04e-05	0.000684	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—APOE—pancreatic cancer	3.04e-05	0.000684	CbGpPWpGaD
Sevoflurane—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	3.03e-05	0.000682	CbGpPWpGaD
Sevoflurane—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	2.97e-05	0.00067	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—HRAS—pancreatic cancer	2.96e-05	0.000667	CbGpPWpGaD
Sevoflurane—ALB—Platelet degranulation—TGFB1—pancreatic cancer	2.96e-05	0.000666	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PRSS1—pancreatic cancer	2.92e-05	0.000659	CbGpPWpGaD
Sevoflurane—GABRG3—Transmission across Chemical Synapses—HRAS—pancreatic cancer	2.9e-05	0.000654	CbGpPWpGaD
Sevoflurane—GABRB1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	2.86e-05	0.000645	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—TP53—pancreatic cancer	2.84e-05	0.00064	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	2.83e-05	0.000637	CbGpPWpGaD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—pancreatic cancer	2.82e-05	0.000635	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PIK3CG—pancreatic cancer	2.74e-05	0.000618	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PIK3CG—pancreatic cancer	2.74e-05	0.000618	CbGpPWpGaD
Sevoflurane—GABRA6—Transmission across Chemical Synapses—HRAS—pancreatic cancer	2.71e-05	0.00061	CbGpPWpGaD
Sevoflurane—GABRQ—Neuronal System—HRAS—pancreatic cancer	2.7e-05	0.000609	CbGpPWpGaD
Sevoflurane—CYP2A6—NRF2 pathway—TGFB1—pancreatic cancer	2.69e-05	0.000606	CbGpPWpGaD
Sevoflurane—GABRA4—Transmission across Chemical Synapses—HRAS—pancreatic cancer	2.67e-05	0.000602	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PPARG—pancreatic cancer	2.65e-05	0.000596	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PPARG—pancreatic cancer	2.65e-05	0.000596	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—AKT1—pancreatic cancer	2.61e-05	0.000589	CbGpPWpGaD
Sevoflurane—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—pancreatic cancer	2.6e-05	0.000586	CbGpPWpGaD
Sevoflurane—ALB—Selenium Micronutrient Network—TNF—pancreatic cancer	2.56e-05	0.000577	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ARG2—pancreatic cancer	2.54e-05	0.000572	CbGpPWpGaD
Sevoflurane—GABRB2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	2.44e-05	0.000551	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	2.42e-05	0.000545	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PIK3CD—pancreatic cancer	2.41e-05	0.000543	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PIK3CD—pancreatic cancer	2.41e-05	0.000543	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	2.39e-05	0.000539	CbGpPWpGaD
Sevoflurane—GABRA5—Transmission across Chemical Synapses—HRAS—pancreatic cancer	2.37e-05	0.000535	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	2.36e-05	0.000532	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PRSS1—pancreatic cancer	2.36e-05	0.000532	CbGpPWpGaD
Sevoflurane—GABRA3—Transmission across Chemical Synapses—HRAS—pancreatic cancer	2.33e-05	0.000525	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PRSS1—pancreatic cancer	2.31e-05	0.000521	CbGpPWpGaD
Sevoflurane—GABRA2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	2.29e-05	0.000516	CbGpPWpGaD
Sevoflurane—GABRB3—Transmission across Chemical Synapses—HRAS—pancreatic cancer	2.28e-05	0.000513	CbGpPWpGaD
Sevoflurane—GABRG2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	2.24e-05	0.000504	CbGpPWpGaD
Sevoflurane—GABRG3—Neuronal System—HRAS—pancreatic cancer	2.22e-05	0.000501	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—TYMP—pancreatic cancer	2.22e-05	0.0005	CbGpPWpGaD
Sevoflurane—GABRB1—Neuronal System—HRAS—pancreatic cancer	2.19e-05	0.000494	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—CD44—pancreatic cancer	2.16e-05	0.000488	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	2.1e-05	0.000473	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PIK3CB—pancreatic cancer	2.1e-05	0.000473	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PIK3CB—pancreatic cancer	2.1e-05	0.000473	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IFNA1—pancreatic cancer	2.1e-05	0.000472	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PTGS2—pancreatic cancer	2.08e-05	0.000469	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PTGS2—pancreatic cancer	2.08e-05	0.000469	CbGpPWpGaD
Sevoflurane—GABRA6—Neuronal System—HRAS—pancreatic cancer	2.07e-05	0.000467	CbGpPWpGaD
Sevoflurane—GABRA4—Neuronal System—HRAS—pancreatic cancer	2.05e-05	0.000461	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ARG2—pancreatic cancer	2.05e-05	0.000461	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ARG2—pancreatic cancer	2e-05	0.000452	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PRSS1—pancreatic cancer	1.99e-05	0.000448	CbGpPWpGaD
Sevoflurane—GABRA1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	1.95e-05	0.00044	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IFNA2—pancreatic cancer	1.95e-05	0.00044	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—HRAS—pancreatic cancer	1.87e-05	0.000422	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	1.83e-05	0.000413	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—HRAS—pancreatic cancer	1.82e-05	0.00041	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PTEN—pancreatic cancer	1.81e-05	0.000409	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PTEN—pancreatic cancer	1.81e-05	0.000409	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—TYMP—pancreatic cancer	1.79e-05	0.000403	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GLP1R—pancreatic cancer	1.79e-05	0.000403	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—HRAS—pancreatic cancer	1.79e-05	0.000403	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—DPYD—pancreatic cancer	1.76e-05	0.000396	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—HRAS—pancreatic cancer	1.76e-05	0.000396	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—TYMP—pancreatic cancer	1.75e-05	0.000395	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—HRAS—pancreatic cancer	1.74e-05	0.000393	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ARG2—pancreatic cancer	1.72e-05	0.000388	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—HRAS—pancreatic cancer	1.71e-05	0.000386	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—SLC2A2—pancreatic cancer	1.67e-05	0.000376	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—TYMP—pancreatic cancer	1.51e-05	0.000339	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—HRAS—pancreatic cancer	1.5e-05	0.000337	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	1.47e-05	0.000331	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GLP1R—pancreatic cancer	1.44e-05	0.000325	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	1.43e-05	0.000322	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—DPYD—pancreatic cancer	1.42e-05	0.00032	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GLP1R—pancreatic cancer	1.41e-05	0.000318	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—DPYD—pancreatic cancer	1.39e-05	0.000313	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PLAU—pancreatic cancer	1.38e-05	0.000312	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—SLC2A2—pancreatic cancer	1.35e-05	0.000303	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—SLC2A2—pancreatic cancer	1.32e-05	0.000297	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	1.31e-05	0.000296	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—CD44—pancreatic cancer	1.29e-05	0.000291	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—PIK3CA—pancreatic cancer	1.28e-05	0.000289	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—PIK3CA—pancreatic cancer	1.28e-05	0.000289	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.24e-05	0.00028	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GCG—pancreatic cancer	1.24e-05	0.000279	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CG—pancreatic cancer	1.23e-05	0.000278	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—EGF—pancreatic cancer	1.22e-05	0.000274	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GLP1R—pancreatic cancer	1.21e-05	0.000274	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—DPYD—pancreatic cancer	1.19e-05	0.000269	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—STK11—pancreatic cancer	1.16e-05	0.000262	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—SLC2A2—pancreatic cancer	1.13e-05	0.000255	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.12e-05	0.000253	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	1.12e-05	0.000252	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CD—pancreatic cancer	1.08e-05	0.000244	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.08e-05	0.000244	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.07e-05	0.000242	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—AKT1—pancreatic cancer	1.05e-05	0.000236	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—AKT1—pancreatic cancer	1.05e-05	0.000236	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—CD44—pancreatic cancer	1.04e-05	0.000235	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—CD44—pancreatic cancer	1.02e-05	0.00023	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—TYMS—pancreatic cancer	1e-05	0.000226	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GCG—pancreatic cancer	9.99e-06	0.000225	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.86e-06	0.000222	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GCG—pancreatic cancer	9.79e-06	0.000221	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CB—pancreatic cancer	9.44e-06	0.000213	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—STK11—pancreatic cancer	9.39e-06	0.000212	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ARG2—pancreatic cancer	9.3e-06	0.00021	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—STK11—pancreatic cancer	9.2e-06	0.000207	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	9.12e-06	0.000205	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—CD44—pancreatic cancer	8.77e-06	0.000198	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	8.59e-06	0.000194	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	8.51e-06	0.000192	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GCG—pancreatic cancer	8.41e-06	0.00019	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—APOE—pancreatic cancer	8.15e-06	0.000184	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—TYMP—pancreatic cancer	8.13e-06	0.000183	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—TYMS—pancreatic cancer	8.08e-06	0.000182	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—TYMS—pancreatic cancer	7.92e-06	0.000178	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—STK11—pancreatic cancer	7.91e-06	0.000178	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—SRC—pancreatic cancer	7.56e-06	0.00017	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	7.42e-06	0.000167	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—VEGFA—pancreatic cancer	7.36e-06	0.000166	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CG—pancreatic cancer	7.35e-06	0.000166	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—NRAS—pancreatic cancer	7.27e-06	0.000164	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PPARG—pancreatic cancer	7.1e-06	0.00016	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—TYMS—pancreatic cancer	6.8e-06	0.000153	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TGFB1—pancreatic cancer	6.76e-06	0.000152	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—APOE—pancreatic cancer	6.57e-06	0.000148	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GLP1R—pancreatic cancer	6.55e-06	0.000148	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CD—pancreatic cancer	6.46e-06	0.000146	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—DPYD—pancreatic cancer	6.44e-06	0.000145	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—APOE—pancreatic cancer	6.44e-06	0.000145	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—KRAS—pancreatic cancer	6.26e-06	0.000141	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	6.12e-06	0.000138	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CG—pancreatic cancer	5.93e-06	0.000134	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CG—pancreatic cancer	5.81e-06	0.000131	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PIK3CA—pancreatic cancer	5.75e-06	0.00013	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PPARG—pancreatic cancer	5.72e-06	0.000129	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CB—pancreatic cancer	5.63e-06	0.000127	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PPARG—pancreatic cancer	5.61e-06	0.000126	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTGS2—pancreatic cancer	5.58e-06	0.000126	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TP53—pancreatic cancer	5.56e-06	0.000125	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—APOE—pancreatic cancer	5.53e-06	0.000125	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—HRAS—pancreatic cancer	5.32e-06	0.00012	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.24e-06	0.000118	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CD—pancreatic cancer	5.21e-06	0.000118	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CD—pancreatic cancer	5.11e-06	0.000115	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CG—pancreatic cancer	4.99e-06	0.000113	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PTEN—pancreatic cancer	4.87e-06	0.00011	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PPARG—pancreatic cancer	4.82e-06	0.000109	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—CD44—pancreatic cancer	4.74e-06	0.000107	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—AKT1—pancreatic cancer	4.7e-06	0.000106	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CB—pancreatic cancer	4.54e-06	0.000102	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GCG—pancreatic cancer	4.54e-06	0.000102	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTGS2—pancreatic cancer	4.5e-06	0.000102	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	4.45e-06	0.0001	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTGS2—pancreatic cancer	4.41e-06	9.94e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CD—pancreatic cancer	4.39e-06	9.89e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—STK11—pancreatic cancer	4.27e-06	9.62e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PTEN—pancreatic cancer	3.93e-06	8.85e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PTEN—pancreatic cancer	3.85e-06	8.67e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CB—pancreatic cancer	3.83e-06	8.62e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTGS2—pancreatic cancer	3.79e-06	8.54e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.67e-06	8.28e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PIK3CA—pancreatic cancer	3.43e-06	7.74e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PTEN—pancreatic cancer	3.31e-06	7.45e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—APOE—pancreatic cancer	2.99e-06	6.73e-05	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—AKT1—pancreatic cancer	2.81e-06	6.32e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PIK3CA—pancreatic cancer	2.77e-06	6.25e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	2.71e-06	6.12e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.7e-06	6.08e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.6e-06	5.86e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.37e-06	5.34e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PIK3CA—pancreatic cancer	2.33e-06	5.26e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—AKT1—pancreatic cancer	2.26e-06	5.1e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—AKT1—pancreatic cancer	2.22e-06	5e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.07e-06	4.66e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.05e-06	4.61e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—AKT1—pancreatic cancer	1.91e-06	4.29e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.78e-06	4.02e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.26e-06	2.84e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.03e-06	2.32e-05	CbGpPWpGaD
